Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue    
Revenue
Other Revenue 1,144
Total revenue 1,144
Operating expenses:    
Research and development, net of reimbursements 18,031 16,085
General and administrative 8,077 6,308
Total operating expenses 26,108 22,393
Loss from operations (24,964) (22,393)
Other income:    
Interest income - net 190 178
Total other income 190 178
Net loss (24,774) (22,215)
Deemed dividend for warrant down-round protection provision (1)
Net loss applicable to common stockholders $ (24,774) $ (22,216)
Net loss per common share - basic and diluted (in Dollars per share) $ (1.2) $ (1.83)
Weighted average common shares outstanding - basic and diluted (in Shares) 20,568,373 12,134,259